-
1
-
-
12344262349
-
Bundeszentrale für gesundheitliche Aufklärung
-
Köln: Aids von A bis Z; Neuauflage
-
Bundeszentrale für gesundheitliche Aufklärung, Köln: Aids von A bis Z; Neuauflage 2002
-
(2002)
-
-
-
2
-
-
33750077642
-
Deutsche AIDS-Hilfe e.V.: Der heutige Wissensstand 28
-
überarbeitete Auflage
-
Deutsche AIDS-Hilfe e.V.: Der heutige Wissensstand 28. überarbeitete Auflage, 2002
-
(2002)
-
-
-
3
-
-
16944366011
-
Maternal Virus Load during Pregnancy and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: The French Perinatal Cohort Studies
-
Mayaux MJ, Dussaix E, Isopet J et al.: Maternal Virus Load during Pregnancy and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: The French Perinatal Cohort Studies. J Infect Dis 1997; 175: 172-175
-
(1997)
J Infect Dis
, vol.175
, pp. 172-175
-
-
Mayaux, M.J.1
Dussaix, E.2
Isopet, J.3
-
4
-
-
10544245018
-
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
-
Sperling RS, Shapiro DE, Coombs RW et al.: Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. N Engl J Med 1996; 335: 1621-1629
-
(1996)
N Engl J Med
, vol.335
, pp. 1621-1629
-
-
Sperling, R.S.1
Shapiro, D.E.2
Coombs, R.W.3
-
5
-
-
0036239507
-
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission
-
Cooper ER, Charurat M, Mofenson L et al.: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. JAIDS 2002; 29: 484-494
-
(2002)
JAIDS
, vol.29
, pp. 484-494
-
-
Cooper, E.R.1
Charurat, M.2
Mofenson, L.3
-
6
-
-
0038078685
-
Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers
-
Poirier MC, Divi RL, Al-Harthi L et al.: Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. JAIDS 2003; 32: 175-183
-
(2003)
JAIDS
, vol.32
, pp. 175-183
-
-
Poirier, M.C.1
Divi, R.L.2
Al-Harthi, L.3
-
7
-
-
0042232027
-
Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort
-
Barret B, Tardieu M, Rustin P et al.: Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003; 17:1769-1785
-
(2003)
AIDS
, vol.17
, pp. 1769-1785
-
-
Barret, B.1
Tardieu, M.2
Rustin, P.3
-
8
-
-
0033604060
-
Persistent mitochondrial dysfunction and perinatal exposure to anti-retroviral nucleoside analogues
-
Blanche S, Tardieu M, Rustin P et al.: Persistent mitochondrial dysfunction and perinatal exposure to anti-retroviral nucleoside analogues. Lancet 1999; 354: 1084-1089
-
(1999)
Lancet
, vol.354
, pp. 1084-1089
-
-
Blanche, S.1
Tardieu, M.2
Rustin, P.3
-
9
-
-
0033572374
-
Incorporation of 3′-Azido-3′-Deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose
-
Poirier MC, Patterson TA, Slikker Jr. W, Olivero OA: Incorporation of 3′-Azido-3′-Deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. JAIDS 1999; 22: 477-483
-
(1999)
JAIDS
, vol.22
, pp. 477-483
-
-
Poirier, M.C.1
Patterson, T.A.2
Slikker Jr., W.3
Olivero, O.A.4
-
10
-
-
0033731153
-
Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells
-
Meng Q, Walker DM, Olivero OA et al.: Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci USA 2000; 97: 12667-12671
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 12667-12671
-
-
Meng, Q.1
Walker, D.M.2
Olivero, O.A.3
-
11
-
-
0031944954
-
Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment
-
Scalfaro P, Chesaux JJ, Buchwalder PA et al.: Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Med 1998; 24: 247-250
-
(1998)
Intensive Care Med
, vol.24
, pp. 247-250
-
-
Scalfaro, P.1
Chesaux, J.J.2
Buchwalder, P.A.3
-
12
-
-
0037379462
-
Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women
-
European Collaborative Study
-
European Collaborative Study: Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. JAIDS 2003; 32: 380-387
-
(2003)
JAIDS
, vol.32
, pp. 380-387
-
-
-
13
-
-
46149144608
-
Routinemäßige Gabe von Zidovudin an HIV-infizierte Schwangere
-
Wahn V: Routinemäßige Gabe von Zidovudin an HIV-infizierte Schwangere. Dt Ärztebl 1995; 92:A-3397-3398
-
(1995)
Dt Ärztebl
, vol.92
-
-
Wahn, V.1
-
14
-
-
16944361839
-
Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1
-
Frenkel LM, Cowles MK, Shapiro DE et al.: Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1. J Infect Dis 1997; 175: 971-974
-
(1997)
J Infect Dis
, vol.175
, pp. 971-974
-
-
Frenkel, L.M.1
Cowles, M.K.2
Shapiro, D.E.3
-
15
-
-
0030013531
-
Obstetrical Factors and The Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child
-
Landesmann SH, Kalish LA, Burns DN et al.: Obstetrical Factors and The Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child. N Engl J Med 1996; 334:1617-1623
-
(1996)
N Engl J Med
, vol.334
, pp. 1617-1623
-
-
Landesmann, S.H.1
Kalish, L.A.2
Burns, D.N.3
-
16
-
-
0032123511
-
Perinatal HIV-1 Transmission. Interaction between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort
-
Mandelbrot L, Le Chenadec J, Berrebi A et al.: Perinatal HIV-1 Transmission. Interaction between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort. JAMA 1998; 280: 55-60
-
(1998)
JAMA
, vol.280
, pp. 55-60
-
-
Mandelbrot, L.1
Le Chenadec, J.2
Berrebi, A.3
-
17
-
-
0031017125
-
Maternal Immunologic and Virologic Risk Factors for Infant Human Immunodeficiency Virus Type 1 Infection: Findings from the Women and Infants Transmission Study
-
Pitt J, Brambilla D, Reichelderfer P et al.: Maternal Immunologic and Virologic Risk Factors for Infant Human Immunodeficiency Virus Type 1 Infection: Findings from the Women and Infants Transmission Study. J Infect Dis 1997; 175: 567-575
-
(1997)
J Infect Dis
, vol.175
, pp. 567-575
-
-
Pitt, J.1
Brambilla, D.2
Reichelderfer, P.3
-
18
-
-
0031954082
-
Transport of Viruses Through Fetal Membranes: An In Vitro Model of Perinatal Transmission
-
Rokos K, Wang H, Seeger J et al.: Transport of Viruses Through Fetal Membranes: An In Vitro Model of Perinatal Transmission. J Med Virology 1998; 54: 313-319
-
(1998)
J Med Virology
, vol.54
, pp. 313-319
-
-
Rokos, K.1
Wang, H.2
Seeger, J.3
-
19
-
-
0029951260
-
Vertical transmission of HIV-1: Maternal immune status and obstetric factors
-
The European Collaborative Study
-
The European Collaborative Study: Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996; 10: 1675-1681
-
(1996)
AIDS
, vol.10
, pp. 1675-1681
-
-
-
20
-
-
0030772885
-
Immunological markers in HIV-infected pregnant women
-
The European Collaborative Study
-
The European Collaborative Study: Immunological markers in HIV-infected pregnant women. AIDS 1997; 11: 1859-1865
-
(1997)
AIDS
, vol.11
, pp. 1859-1865
-
-
-
21
-
-
0037314746
-
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women
-
Tuomala RE, O'Driscoll PT, Bremer JW et al.: Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. JID 2003; 187: 375-384
-
(2003)
JID
, vol.187
, pp. 375-384
-
-
Tuomala, R.E.1
O'Driscoll, P.T.2
Bremer, J.W.3
-
22
-
-
0030898198
-
Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1
-
Burns DN, Landesman S, Wright, DJ et al.: Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis 1997; 175:1206-1210
-
(1997)
J Infect Dis
, vol.175
, pp. 1206-1210
-
-
Burns, D.N.1
Landesman, S.2
Wright, D.J.3
-
23
-
-
0033764669
-
Exposure to HIV-1 during delivery and mother-to-child transmission
-
Gaillard P, Verhofstede C, Mwanyumba F et al.: Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000; 14: 2341-2348
-
(2000)
AIDS
, vol.14
, pp. 2341-2348
-
-
Gaillard, P.1
Verhofstede, C.2
Mwanyumba, F.3
-
24
-
-
0035094157
-
Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration
-
Wright TC Jr, Subbarao S, Ellerbrock TV et al.: Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol. 2001; 184: 279-285
-
(2001)
Am J Obstet Gynecol.
, vol.184
, pp. 279-285
-
-
Wright Jr., T.C.1
Subbarao, S.2
Ellerbrock, T.V.3
-
25
-
-
0036499954
-
Placental inflammation and perinatal transmission of HIV-1
-
Mwanyumba F, Gaillard P, Inion I et al.: Placental inflammation and perinatal transmission of HIV-1. JAIDS 2002; 29: 262-269
-
(2002)
JAIDS
, vol.29
, pp. 262-269
-
-
Mwanyumba, F.1
Gaillard, P.2
Inion, I.3
-
26
-
-
0032556960
-
Prevention of vertical HIV transmission: Additive protective effect of elective Cesarean section and zidovudine prophylaxis
-
Kind Ch, Rudin Ch, Siegrist C et al.: Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. AIDS 1998; 12: 205-210
-
(1998)
AIDS
, vol.12
, pp. 205-210
-
-
Kind, C.H.1
Rudin, C.H.2
Siegrist, C.3
-
27
-
-
0029876109
-
Die HIV-Infektion in Geburtshilfe und Gynäkologie
-
Schäfer APA: Die HIV-Infektion in Geburtshilfe und Gynäkologie. Gynäkologe 1996; 29:129-137
-
(1996)
Gynäkologe
, vol.29
, pp. 129-137
-
-
Schäfer, A.P.A.1
-
28
-
-
33750040595
-
Influence of cesarean section before parturition and antiretroviral prophylaxis on the materno-fetal transmission of HIV
-
12th World AIDS Conference Geneva, June 28-July 3 Poster LB 12466
-
Schäfer A, Friese K, Lauper U et al.: Influence of cesarean section before parturition and antiretroviral prophylaxis on the materno-fetal transmission of HIV. 12th World AIDS Conference Geneva, June 28-July 3 1998, Poster LB 12466
-
(1998)
-
-
Schäfer, A.1
Friese, K.2
Lauper, U.3
-
29
-
-
13844312888
-
German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004)
-
URL: unter Leithnien
-
Salzberger B, Marcus U, Vielhaber B et al.: German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004). Eur J Med Res. 2004; 9(11): 491-504 URL: http:// www.daignet.de unter Leithnien
-
(2004)
Eur J Med Res.
, vol.9
, Issue.11
, pp. 491-504
-
-
Salzberger, B.1
Marcus, U.2
Vielhaber, B.3
-
30
-
-
0012565358
-
Pregnancy and HIV infection: A european consensus on management
-
Coll O, Fiore S, Floridia M et al.: Pregnancy and HIV infection: A european consensus on management. AIDS 2002; 16 (Suppl 2): S1-18
-
(2002)
AIDS
, vol.16
, Issue.SUPPL. 2
-
-
Coll, O.1
Fiore, S.2
Floridia, M.3
-
31
-
-
0003176164
-
Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States
-
CDC Public Health Service Task Force 47/RR2
-
CDC Public Health Service Task Force: Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States. MMWR 1998; 47/RR2
-
(1998)
MMWR
-
-
-
32
-
-
4243522918
-
Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
-
CDC 47/RR-5
-
CDC: Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. MMWR 1998; 47/RR-5
-
(1998)
MMWR
-
-
-
33
-
-
0037340734
-
Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women
-
Justman JE, Benning L, Danoff A et al.: Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. JAIDS 2003; 32: 298-302
-
(2003)
JAIDS
, vol.32
, pp. 298-302
-
-
Justman, J.E.1
Benning, L.2
Danoff, A.3
-
34
-
-
0032564576
-
Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects
-
(Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study)
-
Lorenzi P, Spicher VM, Laubereau B et al. (Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study): Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998; 12 (18): F 241-247
-
(1998)
AIDS
, vol.12
, Issue.18
-
-
Lorenzi, P.1
Spicher, V.M.2
Laubereau, B.3
-
35
-
-
0037068948
-
Pre-eclampsia, antiretroviral therapy, and immune reconstitution
-
Wimalasundera RC, Larbalestier N, Smith JH et al.: Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002, 360: 1152-1154
-
(2002)
Lancet
, vol.360
, pp. 1152-1154
-
-
Wimalasundera, R.C.1
Larbalestier, N.2
Smith, J.H.3
-
36
-
-
0037071791
-
Antiretroviral therapy during pregnancy and the risk of an adverse outcome
-
Tuomala RE, Shapiro DE, Mofenson LM et al.: Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002; 346:1863-1870
-
(2002)
N Engl J Med
, vol.346
, pp. 1863-1870
-
-
Tuomala, R.E.1
Shapiro, D.E.2
Mofenson, L.M.3
-
37
-
-
0037065567
-
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: A prospective cohort study
-
Conley LJ, Ellerbrock TV, Bush TJ et al.: HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002; 359: 108-113
-
(2002)
Lancet
, vol.359
, pp. 108-113
-
-
Conley, L.J.1
Ellerbrock, T.V.2
Bush, T.J.3
-
38
-
-
19944403922
-
Updated European recommendations for the clinical use of HIV drug resistance testing
-
Vandamme AM, Sonnerborg A, Ait-Khaled M et al.: Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004; 9(6): 829-848
-
(2004)
Antivir Ther
, vol.9
, Issue.6
, pp. 829-848
-
-
Vandamme, A.M.1
Sonnerborg, A.2
Ait-Khaled, M.3
-
39
-
-
0034105783
-
HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the Women and Infants Transmission Study
-
The Women and Infants Transmission Study Group
-
Welles SL, Pitt J, Colgrove R and The Women and Infants Transmission Study Group: HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the Women and Infants Transmission Study. AIDS 2000; 14:263-271
-
(2000)
AIDS
, vol.14
, pp. 263-271
-
-
Welles, S.L.1
Pitt, J.2
Colgrove, R.3
-
40
-
-
0035280397
-
Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study
-
Duwe S, Brunn M, Altmann D et al.: Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study. JAIDS 2001; 26: 266-273
-
(2001)
JAIDS
, vol.26
, pp. 266-273
-
-
Duwe, S.1
Brunn, M.2
Altmann, D.3
-
41
-
-
0031912007
-
Maternal Viral Genotypic Zidovudine Resistance and Infrequent Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric Clinical Trial Protocol 076
-
Eastman PS, Shapiro DE, Coombs RW et al.: Maternal Viral Genotypic Zidovudine Resistance and Infrequent Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric Clinical Trial Protocol 076. J Infect Dis 1998; 177: 557-564
-
(1998)
J Infect Dis
, vol.177
, pp. 557-564
-
-
Eastman, P.S.1
Shapiro, D.E.2
Coombs, R.W.3
-
42
-
-
0035946701
-
Lamivudine-Zidovudine combination for prevention of maternal-infant transmission of HIV-1
-
Mandelbrot L, Landreau-Mascaro A, Rekacewicz C et al.: Lamivudine-Zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001; 285: 2083-2093
-
(2001)
JAMA
, vol.285
, pp. 2083-2093
-
-
Mandelbrot, L.1
Landreau-Mascaro, A.2
Rekacewicz, C.3
-
43
-
-
0033816265
-
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
-
Jackson JB, Becker-Pergola G, Guay LA et al.: Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS 2000; 14: F111-F115
-
(2000)
AIDS
, vol.14
-
-
Jackson, J.B.1
Becker-Pergola, G.2
Guay, L.A.3
-
44
-
-
20844453585
-
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP
-
Eshleman SH, Hoover DR, Chen S et al.: Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis 2005; 192(1): 30-36
-
(2005)
J Infect Dis
, vol.192
, Issue.1
, pp. 30-36
-
-
Eshleman, S.H.1
Hoover, D.R.2
Chen, S.3
-
45
-
-
33750073583
-
-
Sustiva Capsules Product Monograph
-
Sustiva Capsules Product Monograph 1998
-
(1998)
-
-
-
46
-
-
33750063699
-
-
BMS Warning Letter, 5. January
-
BMS Warning Letter, 5. January 2001
-
(2001)
-
-
-
47
-
-
0028970597
-
CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: Evidence for pregnancy-induced immune depression in uninfected and HIV-infected women
-
Rich KC, Siegel JN, Jennings C et al.: CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis 1995; 172: 1221-1227
-
(1995)
J Infect Dis
, vol.172
, pp. 1221-1227
-
-
Rich, K.C.1
Siegel, J.N.2
Jennings, C.3
-
48
-
-
0037867606
-
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
-
Kosel BW, Beckerman KP, Hayashi S et al.: Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women. AIDS 2003; 17:1195-1199
-
(2003)
AIDS
, vol.17
, pp. 1195-1199
-
-
Kosel, B.W.1
Beckerman, K.P.2
Hayashi, S.3
-
49
-
-
17344368990
-
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team
-
Mirochnick M, Fenton T, Gagnier P et al.: Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis 1998; 178: 368-374
-
(1998)
J Infect Dis
, vol.178
, pp. 368-374
-
-
Mirochnick, M.1
Fenton, T.2
Gagnier, P.3
-
50
-
-
0032728821
-
Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus-infected pregnant women and their neonates: An AIDS clinical trials group study
-
Wang Y, Livingston E, Patil S, et al.: Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus-infected pregnant women and their neonates: an AIDS clinical trials group study. J Infect Dis 1999; 180: 1536-1541
-
(1999)
J Infect Dis
, vol.180
, pp. 1536-1541
-
-
Wang, Y.1
Livingston, E.2
Patil, S.3
-
51
-
-
0028144849
-
Metabolism of 3′-Azido-3′-Deoxythymidine (AZT) in Human Placental Trophophlasts and Hofbauer Cells
-
Qian M, Bui T, Ho RJY et al.: Metabolism of 3′-Azido-3′-Deoxythymidine (AZT) in Human Placental Trophophlasts and Hofbauer Cells. Biochemical Pharmacology 1994; 48: 383-389
-
(1994)
Biochemical Pharmacology
, vol.48
, pp. 383-389
-
-
Qian, M.1
Bui, T.2
Ho, R.J.Y.3
-
52
-
-
0037446447
-
Phosphorylation of 3′-Azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and and at term
-
Agbaria R, Manor E, Barak J et al.: Phosphorylation of 3′-Azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and and at term. JAIDS 2003; 32: 477-481
-
(2003)
JAIDS
, vol.32
, pp. 477-481
-
-
Agbaria, R.1
Manor, E.2
Barak, J.3
-
53
-
-
0034679252
-
Pharmacological implications of lengthened in-utero exposure to nevirapine
-
Taylor GP, Lyall EGH, Back D et al.: Pharmacological implications of lengthened in-utero exposure to nevirapine. Lancet 2000; 355: 2134-2135
-
(2000)
Lancet
, vol.355
, pp. 2134-2135
-
-
Taylor, G.P.1
Lyall, E.G.H.2
Back, D.3
-
54
-
-
0037066372
-
Transplacental passage of protease inhibitors at delivery
-
Marzolini C, Rudin C, Decosterd LA et al.: Transplacental passage of protease inhibitors at delivery. AIDS 2002; 16: 889-893
-
(2002)
AIDS
, vol.16
, pp. 889-893
-
-
Marzolini, C.1
Rudin, C.2
Decosterd, L.A.3
-
55
-
-
0036375115
-
Concentrations of protease inhibitors in cord blood after in utero exposure
-
Mirochnick M, Dorenbaum A, Holland D et al.: Concentrations of protease inhibitors in cord blood after in utero exposure. Pediatr Infect Dis J 2002; 21 (9): 835-838
-
(2002)
Pediatr Infect Dis J
, vol.21
, Issue.9
, pp. 835-838
-
-
Mirochnick, M.1
Dorenbaum, A.2
Holland, D.3
-
56
-
-
0038417259
-
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose
-
Mirochnick M, Dorenbaum A, Blanchard S et al.: Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose. JAIDS 2003; 33(2): 153-156
-
(2003)
JAIDS
, vol.33
, Issue.2
, pp. 153-156
-
-
Mirochnick, M.1
Dorenbaum, A.2
Blanchard, S.3
-
58
-
-
0004293174
-
-
New York: Churchill Livingstone
-
Larsen WJ: Human Embryology. New York: Churchill Livingstone, 1993
-
(1993)
Human Embryology
-
-
Larsen, W.J.1
-
60
-
-
0003922888
-
Arzneiverordnung in Schwangerschaft und Stillzeit
-
5. Aufl., Stuttgart, Gustav Fischer
-
Spielmann H, Steinhoff R, Schaefer C et al.: Arzneiverordnung in Schwangerschaft und Stillzeit. 5. Aufl., Stuttgart, Gustav Fischer, 1998
-
(1998)
-
-
Spielmann, H.1
Steinhoff, R.2
Schaefer, C.3
-
61
-
-
0028003766
-
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
-
Connor EM, Sperling RS, Gelber R et al.: Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. N Engl J Med 1994; 331:1173-1180
-
(1994)
N Engl J Med
, vol.331
, pp. 1173-1180
-
-
Connor, E.M.1
Sperling, R.S.2
Gelber, R.3
-
62
-
-
0242289041
-
Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission
-
Chuachoowong R, Shaffer N, Siriwasin W et al.: Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. J Inf Dis 2000; 181: 99-106
-
(2000)
J Inf Dis
, vol.181
, pp. 99-106
-
-
Chuachoowong, R.1
Shaffer, N.2
Siriwasin, W.3
-
63
-
-
0034610026
-
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1
-
Lallemant M, Jourdain G, Le Coeur S et al.: A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Eng J Med 2000; 343: 982-991
-
(2000)
N Eng J Med
, vol.343
, pp. 982-991
-
-
Lallemant, M.1
Jourdain, G.2
Le Coeur, S.3
-
64
-
-
0032511952
-
Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
-
Wade NA, Birkhead GS, Warren BL et al.: Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339: 1409-1414
-
(1998)
N Engl J Med
, vol.339
, pp. 1409-1414
-
-
Wade, N.A.1
Birkhead, G.S.2
Warren, B.L.3
-
65
-
-
0038128513
-
Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments
-
Mbori-Ngacha D, Richardson BA, Overbaugh J et al.: Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments. J Virol 2003; 77: 7702-7705
-
(2003)
J Virol
, vol.77
, pp. 7702-7705
-
-
Mbori-Ngacha, D.1
Richardson, B.A.2
Overbaugh, J.3
-
66
-
-
0037040374
-
Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine
-
Ekpini RA, Nkengasong JN, Sibailly T et al.: Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS 2002; 16: 625-630
-
(2002)
AIDS
, vol.16
, pp. 625-630
-
-
Ekpini, R.A.1
Nkengasong, J.N.2
Sibailly, T.3
-
67
-
-
0031912007
-
Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076
-
Eastman PS, Shapiro DE, Coombs RW et al.: Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis 1998; 177:557-564
-
(1998)
J Infect Dis
, vol.177
, pp. 557-564
-
-
Eastman, P.S.1
Shapiro, D.E.2
Coombs, R.W.3
-
68
-
-
0037321530
-
Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival
-
Bardeguez AD, Shapiro DE, Mofenson LM et al.: Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. JAIDS 2003; 32: 170-181
-
(2003)
JAIDS
, vol.32
, pp. 170-181
-
-
Bardeguez, A.D.1
Shapiro, D.E.2
Mofenson, L.M.3
-
69
-
-
0032880154
-
Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy
-
Clarke JR, Braganza R, Mirza A et al.: Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy. J Med Virol 1999; 59:364-368
-
(1999)
J Med Virol
, vol.59
, pp. 364-368
-
-
Clarke, J.R.1
Braganza, R.2
Mirza, A.3
-
70
-
-
0027243089
-
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082)
-
O'Sullivan M, Boyer P, Scott G et al.: The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082). Am J Obstet Gynecol 1993; 168: 1510-1516
-
(1993)
Am J Obstet Gynecol
, vol.168
, pp. 1510-1516
-
-
O'Sullivan, M.1
Boyer, P.2
Scott, G.3
-
71
-
-
0033527028
-
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
-
Garcia PM, Kalish LA, Pitt J et al.: Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Eng J Med 1999; 341: 394-402
-
(1999)
N Eng J Med
, vol.341
, pp. 394-402
-
-
Garcia, P.M.1
Kalish, L.A.2
Pitt, J.3
-
72
-
-
0033526986
-
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
-
Mofenson LM, Lambert JS, Stiehm ER et al.: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Eng J Med 1999; 341: 385-393
-
(1999)
N Eng J Med
, vol.341
, pp. 385-393
-
-
Mofenson, L.M.1
Lambert, J.S.2
Stiehm, E.R.3
-
73
-
-
0032867780
-
Maternal viral load and vertical transmission of HIV-1: An important factor but not the only one
-
The European Collaborative Study
-
The European Collaborative Study: Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999; 13: 1377-85
-
(1999)
AIDS
, vol.13
, pp. 1377-1385
-
-
-
74
-
-
0033377940
-
Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand
-
Shaffer N, Roongpisuthipong A, Siriwasin W et al.: Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. J Inf Dis 1999; 179: 590-599
-
(1999)
J Inf Dis
, vol.179
, pp. 590-599
-
-
Shaffer, N.1
Roongpisuthipong, A.2
Siriwasin, W.3
-
76
-
-
0033119011
-
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - A meta-analysis of 15 prospective cohort studies
-
The International Perinatal HIV Group
-
The International Perinatal HIV Group: The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Eng J Med 1999; 340: 977-987
-
(1999)
N Eng J Med
, vol.340
, pp. 977-987
-
-
-
77
-
-
0028765439
-
Recommendations of the U-S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus
-
CDC 43/RR-11
-
CDC: Recommendations of the U-S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus. MMWR 1994; 43/RR-11
-
(1994)
MMWR
-
-
-
78
-
-
0034524873
-
An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection
-
Grosch-Wörner I, Schäfer A, Obladen M et al.: An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 2000; 14: 2903-2911
-
(2000)
AIDS
, vol.14
, pp. 2903-2911
-
-
Grosch-Wörner, I.1
Schäfer, A.2
Obladen, M.3
-
79
-
-
0028173861
-
Cigarette smoking, premature rupture of membranes and vertical transmission of HIV1 among women with low CD4+ levels
-
Burns DN, Landesman S, Muenz LR et al.: Cigarette smoking, premature rupture of membranes and vertical transmission of HIV1 among women with low CD4+ levels. JAIDS 1994; 7: 718-726
-
(1994)
JAIDS
, vol.7
, pp. 718-726
-
-
Burns, D.N.1
Landesman, S.2
Muenz, L.R.3
-
80
-
-
0038417259
-
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose
-
Mirochnick M, Dorenbaum A, Blanchard S et al.: Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose. JAIDS 2003; 33: 153-156
-
(2003)
JAIDS
, vol.33
, pp. 153-156
-
-
Mirochnick, M.1
Dorenbaum, A.2
Blanchard, S.3
-
81
-
-
0043129064
-
Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine
-
Stringer JSA, Sinkala M, Chapman V et al.: Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS 2003; 17: 1659-1665
-
(2003)
AIDS
, vol.17
, pp. 1659-1665
-
-
Stringer, J.S.A.1
Sinkala, M.2
Chapman, V.3
-
82
-
-
3042848856
-
Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: A randomized controlled trial
-
Taha TE, Kumwenda NI, Hoover DR et al.: Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 2004; 292(2): 202-209
-
(2004)
JAMA
, vol.292
, Issue.2
, pp. 202-209
-
-
Taha, T.E.1
Kumwenda, N.I.2
Hoover, D.R.3
-
83
-
-
3142656082
-
Perinatal HIV Prevention Trial (Thailand) Investigators: Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
-
Lallemant M, Jourdain G, Le Coeur S et al. Perinatal HIV Prevention Trial (Thailand) Investigators: Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004; 351(3): 217-228
-
(2004)
N Engl J Med.
, vol.351
, Issue.3
, pp. 217-228
-
-
Lallemant, M.1
Jourdain, G.2
Le Coeur, S.3
-
84
-
-
15444365351
-
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission
-
ANRS 1201/1202 DITRAME PLUS Study Group
-
Dabis F, Bequet L, Ekouevi DK et al.: ANRS 1201/1202 DITRAME PLUS Study Group: Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005; 19(3): 309-318.
-
(2005)
AIDS
, vol.19
, Issue.3
, pp. 309-318
-
-
Dabis, F.1
Bequet, L.2
Ekouevi, D.K.3
-
85
-
-
0038386847
-
Duration of ruptured membranes and extended labor are risk factors for HIV transmission
-
Garcia-Tejedor A, Perales A, Maiques V: Duration of ruptured membranes and extended labor are risk factors for HIV transmission. Int J Gynaecol Obstet. 2003; 82(1): 17-23.
-
(2003)
Int J Gynaecol Obstet.
, vol.82
, Issue.1
, pp. 17-23
-
-
Garcia-Tejedor, A.1
Perales, A.2
Maiques, V.3
-
86
-
-
33750044624
-
Deutsch-Österreichische Empfehlungen zur postexpositionellen Prophylaxe nach HIV-Exposition
-
(September 2004) URL
-
Deutsch-Österreichische Empfehlungen zur postexpositionellen Prophylaxe nach HIV-Exposition (September 2004) URL: http://www.rki.de
-
-
-
-
87
-
-
0033523454
-
Intrapartum and neonatal single dose nevirapine compares with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomized trial
-
Guay LA, Musoke P, Fleming T et al: Intrapartum and neonatal single dose nevirapine compares with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomized trial. Lancet 1999; 354: 795-802
-
(1999)
Lancet
, vol.354
, pp. 795-802
-
-
Guay, L.A.1
Musoke, P.2
Fleming, T.3
-
88
-
-
0037333802
-
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1
-
Moodley D, Moodley J, Coovadia H et al.: A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 187: 725-735
-
(2003)
J Infect Dis
, vol.187
, pp. 725-735
-
-
Moodley, D.1
Moodley, J.2
Coovadia, H.3
-
89
-
-
20844437104
-
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012
-
Flys T, Nissley DV, Claasen CW et al.: Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis 2005; 192(1): 24-29
-
(2005)
J Infect Dis
, vol.192
, Issue.1
, pp. 24-29
-
-
Flys, T.1
Nissley, D.V.2
Claasen, C.W.3
-
92
-
-
0035865870
-
CM: Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000copies/ml
-
Ioannidis JPA, Abrams EJ, Ammann A et al.: CM: Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000copies/ml. J Inf Dis 2001; 183: 539-545
-
(2001)
J Inf Dis
, vol.183
, pp. 539-545
-
-
Ioannidis, J.P.A.1
Abrams, E.J.2
Ammann, A.3
-
93
-
-
0032753022
-
Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers
-
Mandelbrot L, Burgard M, Teglas J-P et al.: Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 1999; 13: 2143-2149
-
(1999)
AIDS
, vol.13
, pp. 2143-2149
-
-
Mandelbrot, L.1
Burgard, M.2
Teglas, J.-P.3
-
94
-
-
0035082926
-
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy
-
Debiaggi M, Zara F, Spinillo A et al.: Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Microbiol Infect Dis 2001; 20: 91-96
-
(2001)
Eur J Microbiol Infect Dis
, vol.20
, pp. 91-96
-
-
Debiaggi, M.1
Zara, F.2
Spinillo, A.3
-
95
-
-
0035400159
-
Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions
-
Ellerbrock TV, Lennox JL, Clancy KA et al.: Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis 2001, 184: 28-36
-
(2001)
J Infect Dis
, vol.184
, pp. 28-36
-
-
Ellerbrock, T.V.1
Lennox, J.L.2
Clancy, K.A.3
-
96
-
-
0033914449
-
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy
-
Si-Mohamed A, Kazatchkine MD, Goujon C et al.: Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis 2000, 182: 112-122
-
(2000)
J Infect Dis
, vol.182
, pp. 112-122
-
-
Si-Mohamed, A.1
Kazatchkine, M.D.2
Goujon, C.3
-
97
-
-
0036329526
-
Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy
-
Avidan MS, Groves P, Blott M et al.: Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy. Anesthesiology 2002; 97(2): 320-324
-
(2002)
Anesthesiology
, vol.97
, Issue.2
, pp. 320-324
-
-
Avidan, M.S.1
Groves, P.2
Blott, M.3
-
98
-
-
0035280934
-
Mode of delivery and postpartum morbidity among HIV-infected women: The women and infants transmission study
-
Read J, Tuomala R, Kpamegan E et al.: Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. JAIDS 2001; 26: 236-245
-
(2001)
JAIDS
, vol.26
, pp. 236-245
-
-
Read, J.1
Tuomala, R.2
Kpamegan, E.3
-
99
-
-
0035340096
-
Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women
-
Rodriguez EJ, Spann C, Jamieson D et al.: Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol 2001, 184:1108-1111
-
(2001)
Am J Obstet Gynecol
, vol.184
, pp. 1108-1111
-
-
Rodriguez, E.J.1
Spann, C.2
Jamieson, D.3
-
100
-
-
0033869318
-
Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL
-
Watts DH, Lambert JS, Stiehm ER et al.: Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL. Am J Obstet Gynecol 2000; 183:100-107
-
(2000)
Am J Obstet Gynecol
, vol.183
, pp. 100-107
-
-
Watts, D.H.1
Lambert, J.S.2
Stiehm, E.R.3
-
101
-
-
0034526376
-
Combination antiretroviral therapy and duration of pregnancy
-
European Collaborative Study and the Swiss Mother + Child HIV Cohort Study
-
European Collaborative Study and the Swiss Mother + Child HIV Cohort Study: Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14: 2913-2920
-
(2000)
AIDS
, vol.14
, pp. 2913-2920
-
-
-
102
-
-
0034161409
-
Effect of breastfeeding and formula feeding on Transmission of HIV-1
-
Nduati R, John G, Mbori-Ngacha D et al.: Effect of breastfeeding and formula feeding on Transmission of HIV-1. JAMA 2000; 283: 1167-1174
-
(2000)
JAMA
, vol.283
, pp. 1167-1174
-
-
Nduati, R.1
John, G.2
Mbori-Ngacha, D.3
-
103
-
-
0032953964
-
Transmission of human immunodeficiency virus type 1 through breast-feeding: How can it be prevented?
-
Van de Perre P.: Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented? J Infect Dis. 1999; 179 Suppl 3: S405-407
-
(1999)
J Infect Dis.
, vol.179
, Issue.SUPPL. 3
-
-
Van de Perre, P.1
-
104
-
-
0028862260
-
Human immunodeficiency virus type 1 infected cells in breast milk
-
Nduati RW, John GC, Richardson BA et al.: Human immunodeficiency virus type 1 infected cells in breast milk. Infect Dis 1995; 172: 1461-1468
-
(1995)
Infect Dis
, vol.172
, pp. 1461-1468
-
-
Nduati, R.W.1
John, G.C.2
Richardson, B.A.3
-
105
-
-
0022349942
-
Isolation of AIDS virus from cell-free breastmilk of three healthy virus carriers
-
Thiry L, Spencer-Goldberger S, Jonckheer T et al.: Isolation of AIDS virus from cell-free breastmilk of three healthy virus carriers. Lancet 1985 ii: 891-892
-
(1985)
Lancet
, vol.2
, pp. 891-892
-
-
Thiry, L.1
Spencer-Goldberger, S.2
Jonckheer, T.3
-
106
-
-
85046113809
-
False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus type 1 in children infected with HIV strains of African origin
-
Haas J, Geiss M, Böhler T et al.: False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus type 1 in children infected with HIV strains of African origin. J Infect Dis 1996; 174: 224-225
-
(1996)
J Infect Dis
, vol.174
, pp. 224-225
-
-
Haas, J.1
Geiss, M.2
Böhler, T.3
-
107
-
-
0343317894
-
Early diagnosis of HIV infection in infants - Report of a consensus
-
workshop Siena, Italy, January 17-18, 1992
-
Rossi P, et al.: Early diagnosis of HIV infection in infants - Report of a consensus workshop, Siena, Italy, January 17-18, 1992. JAIDS 1992; 5: 1168-1178
-
(1992)
JAIDS
, vol.5
, pp. 1168-1178
-
-
Rossi, P.1
-
108
-
-
0032540034
-
Guidelines for the use of antiretroviral agents in pediatric HIV infection
-
CENTERS OF DISEASE CONTROL URL
-
CENTERS OF DISEASE CONTROL: Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 1998; 47: 1-43; URL http:// www.hivatis.org
-
(1998)
MMWR
, vol.47
, pp. 1-43
-
-
-
109
-
-
0037238447
-
Pediatric AIDS Clinical Trials Group 331 Investigators: Pharmacokinetics and tolerance of zidovudine in preterm infants
-
Capparelli EV, Mirochnick M, Dankner WM et al.: Pediatric AIDS Clinical Trials Group 331 Investigators: Pharmacokinetics and tolerance of zidovudine in preterm infants. J Pediatr 2003; 142(1): 47- 52
-
(2003)
J Pediatr
, vol.142
, Issue.1
, pp. 47-52
-
-
Capparelli, E.V.1
Mirochnick, M.2
Dankner, W.M.3
-
110
-
-
0037716608
-
HlV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women?
-
Maiques V, Garcia-Tejedor A, Perales A et al: HlV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women? Eur J Obstet Gynecol Reprod Biol 2003; 108(2): 137-141
-
(2003)
Eur J Obstet Gynecol Reprod Biol
, vol.108
, Issue.2
, pp. 137-141
-
-
Maiques, V.1
Garcia-Tejedor, A.2
Perales, A.3
-
111
-
-
0037313784
-
Society of Obstetricians and Gynaecologists of Canada: Amniocentesis and women with hepatitis B, hepatitis C or human immunodeficiency virus
-
149-152
-
Davies G, Wilson RD, Desilets V et al.: Society of Obstetricians and Gynaecologists of Canada: Amniocentesis and women with hepatitis B, hepatitis C or human immunodeficiency virus. J Obstet Gynaecol Can 2003; 25(2): 145-148, 149-152
-
(2003)
J Obstet Gynaecol Can
, vol.25
, Issue.2
, pp. 145-148
-
-
Davies, G.1
Wilson, R.D.2
Desilets, V.3
-
112
-
-
4143074797
-
Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs
-
Poirier MC, Olivero CA, Walker DM et al.: Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol 2004; 199(2): 151-161
-
(2004)
Toxicol Appl Pharmacol
, vol.199
, Issue.2
, pp. 151-161
-
-
Poirier, M.C.1
Olivero, C.A.2
Walker, D.M.3
-
113
-
-
10944246142
-
Pharmacokinetics of antiretrovirals in pregnant women
-
Mirochnick M, Capparelli E et al.: Pharmacokinetics of antiretrovirals in pregnant women. Clin Pharmacokinet 2004; 43(15): 1071-1087
-
(2004)
Clin Pharmacokinet
, vol.43
, Issue.15
, pp. 1071-1087
-
-
Mirochnick, M.1
Capparelli, E.2
-
114
-
-
12144252054
-
Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy
-
Lyons FE, Coughlan S, Byrne CM et al.: Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy. AIDS 2005; 19(1): 63-67
-
(2005)
AIDS
, vol.19
, Issue.1
, pp. 63-67
-
-
Lyons, F.E.1
Coughlan, S.2
Byrne, C.M.3
-
115
-
-
0036603048
-
Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance
-
Review
-
Nolan M, Fowler MG, Molenson LM. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance. J Acquir Immune Defic Syndr. 2002; 30(2): 216-29. Review
-
(2002)
J Acquir Immune Defic Syndr.
, vol.30
, Issue.2
, pp. 216-229
-
-
Nolan, M.1
Fowler, M.G.2
Molenson, L.M.3
-
116
-
-
10244236453
-
Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe
-
Thorne C, Patel D, Newell ML: Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18(17): 2337-2339
-
(2004)
AIDS
, vol.18
, Issue.17
, pp. 2337-2339
-
-
Thorne, C.1
Patel, D.2
Newell, M.L.3
-
117
-
-
2142817146
-
Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery
-
European HIV in Obstetrics Group
-
Fiore S, Newell ML, Thorne C: European HIV in Obstetrics Group: Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 2004; 18(6): 933-938
-
(2004)
AIDS
, vol.18
, Issue.6
, pp. 933-938
-
-
Fiore, S.1
Newell, M.L.2
Thorne, C.3
-
118
-
-
0036264320
-
Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery
-
Marcollet A, Goffinet F, Firtion G et al: Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 2002; 186(4): 784-789
-
(2002)
Am J Obstet Gynecol
, vol.186
, Issue.4
, pp. 784-789
-
-
Marcollet, A.1
Goffinet, F.2
Firtion, G.3
-
119
-
-
0035841613
-
Determinants of HIV-1 shedding in the genital tract of women
-
DATRI Study Group; WIHS Study Group
-
Kovacs A, Wasserman SS, Burns D et al.: DATRI Study Group; WIHS Study Group: Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358(9293): 1593-1601
-
(2001)
Lancet
, vol.358
, Issue.9293
, pp. 1593-1601
-
-
Kovacs, A.1
Wasserman, S.S.2
Burns, D.3
-
120
-
-
10744231331
-
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies
-
Fiore JR, Suligoi B, Saracino A et al.: Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 2003; 17(15): 2169-2176
-
(2003)
AIDS
, vol.17
, Issue.15
, pp. 2169-2176
-
-
Fiore, J.R.1
Suligoi, B.2
Saracino, A.3
-
121
-
-
0037314746
-
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women
-
Women and Infants Transmission Study
-
Tuomala RE, O'Driscoll PT, Bremer JW et al.: Women and Infants Transmission Study: Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187(3): 375-384
-
(2003)
J Infect Dis
, vol.187
, Issue.3
, pp. 375-384
-
-
Tuomala, R.E.1
O'Driscoll, P.T.2
Bremer, J.W.3
-
122
-
-
23344448564
-
Addition of 3 Days of ZDV+3TC Postpartum to a Short Course of ZDV+3TC and Single-dose NVP Provides Low Rate of NVP Resistance Mutations and High Efficacy in Preventing Peri-partum HIV-1 Transmission: ANRS DITRAME Plus, Abidjan, Côte d'Ivoire
-
12th CROI, Boston Abstr. 72LB
-
Chaix ML, Dabis F, Ekouevi D et al.: Addition of 3 Days of ZDV+3TC Postpartum to a Short Course of ZDV+3TC and Single-dose NVP Provides Low Rate of NVP Resistance Mutations and High Efficacy in Preventing Peri-partum HIV-1 Transmission: ANRS DITRAME Plus, Abidjan, Côte d'Ivoire. 12th CROI, Boston 2005, Abstr. 72LB
-
(2005)
-
-
Chaix, M.L.1
Dabis, F.2
Ekouevi, D.3
-
123
-
-
0033526986
-
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
-
Pediatric AIDS Clinical Trials Group Study 185 Team
-
Mofenson LM, Lambert JS, Stiehm ER et al.: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999; 341(6): 385-393
-
(1999)
N Engl J Med.
, vol.341
, Issue.6
, pp. 385-393
-
-
Mofenson, L.M.1
Lambert, J.S.2
Stiehm, E.R.3
-
124
-
-
0033604573
-
Maternal viral load and the risk of perinatal transmission of HIV-1
-
Ioannidis JP, Contopoulos-Ioannidis DG: Maternal viral load and the risk of perinatal transmission of HIV-1. N Engl J Med. 1999; 341(22): 1698-1700
-
(1999)
N Engl J Med.
, vol.341
, Issue.22
, pp. 1698-1700
-
-
Ioannidis, J.P.1
Contopoulos-Ioannidis, D.G.2
-
125
-
-
4444287093
-
Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus
-
Chappuy H, Treluyer JM, Rey E et al.: Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol. 2004; 191(2): 558-562
-
(2004)
Am J Obstet Gynecol.
, vol.191
, Issue.2
, pp. 558-562
-
-
Chappuy, H.1
Treluyer, J.M.2
Rey, E.3
-
127
-
-
4744362280
-
Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough
-
Meyohas MC, Lacombe K, Carbonne B et al.: Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough. AIDS 2004; 18(14): 1966-1968
-
(2004)
AIDS
, vol.18
, Issue.14
, pp. 1966-1968
-
-
Meyohas, M.C.1
Lacombe, K.2
Carbonne, B.3
-
129
-
-
0028794926
-
The sensitivity of HIV1-DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission
-
Dunn DT, Brandt CD, Kirvine A et al.: The sensitivity of HIV1-DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995; 9(9): F7-11
-
(1995)
AIDS
, vol.9
, Issue.9
-
-
Dunn, D.T.1
Brandt, C.D.2
Kirvine, A.3
-
130
-
-
0036904870
-
Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand
-
Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A et al.: Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. Clin Infect Dis 2002 35(11): 1405-1413
-
(2002)
Clin Infect Dis
, vol.35
, Issue.11
, pp. 1405-1413
-
-
Chaisilwattana, P.1
Chokephaibulkit, K.2
Chalermchockcharoenkit, A.3
-
131
-
-
0035853373
-
HIV-infected pregnant women and vertical transmission in Europe since 1986
-
European collaborative study
-
European collaborative study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS. 2001 15(6): 761-770
-
(2001)
AIDS
, vol.15
, Issue.6
, pp. 761-770
-
-
-
132
-
-
13444300922
-
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy
-
European Collaborative Study
-
European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005 40(3): 458-465
-
(2005)
Clin Infect Dis
, vol.40
, Issue.3
, pp. 458-465
-
-
-
133
-
-
23244437092
-
Highly active antiretroviral therapy (HAARI) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 study
-
Ananworanich J, Siangphoe U, Hill A et al.: Highly active antiretroviral therapy (HAARI) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study. JAIDS 2005; 39(5): 523-529
-
(2005)
JAIDS
, vol.39
, Issue.5
, pp. 523-529
-
-
Ananworanich, J.1
Siangphoe, U.2
Hill, A.3
-
134
-
-
24644469032
-
Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4(+) cells/microl? Impact on immunovirological parameters
-
Pellegrin I, Thiebaut R, Blanco P et al.: Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4(+) cells/microl? Impact on immunovirological parameters. J Med Virol 2005; 77(2): 164-172
-
(2005)
J Med Virol
, vol.77
, Issue.2
, pp. 164-172
-
-
Pellegrin, I.1
Thiebaut, R.2
Blanco, P.3
|